NASDAQ:AMST Amesite Q4 2024 Earnings Report $3.21 -0.01 (-0.31%) Closing price 09/19/2025 04:00 PM EasternExtended Trading$3.20 -0.01 (-0.28%) As of 09/19/2025 07:50 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. ProfileEarnings History Amesite EPS ResultsActual EPS-$0.46Consensus EPS N/ABeat/MissN/AOne Year Ago EPSN/AAmesite Revenue ResultsActual Revenue$0.03 millionExpected RevenueN/ABeat/MissN/AYoY Revenue GrowthN/AAmesite Announcement DetailsQuarterQ4 2024Date9/30/2024TimeN/AConference Call DateSunday, September 29, 2024Conference Call Time6:00PM ETUpcoming EarningsAmesite's Q4 2025 earnings is scheduled for Monday, September 29, 2025, with a conference call scheduled on Sunday, September 28, 2025 at 6:00 PM ET. Check back for transcripts, audio, and key financial metrics as they become available.Conference Call ResourcesAnnual Report (10-K)Earnings HistoryCompany ProfilePowered by Earnings DocumentsAnnual report(10-K) Amesite Earnings HeadlinesAmesite stock soars after reporting 63% revenue growth from NurseMagicSeptember 11, 2025 | investing.comAmesite reports 63% revenue growth from NurseMagic EnterpriseSeptember 11, 2025 | msn.comPrepare for the “Mar-a-Lago Accord” Money ShockWhy Are Wall Street Insiders Moving Their Money to This ONE Asset? Something far more consequential for your money than tariffs is unfolding behind the scenes... Tucked inside this overlooked directive is a plan set to be executed for the first time in in U.S. history. One Stansberry Research's Senior Partner says it's set to trigger a rare window for potentially explosive gains in ONE asset immediately. (Not AI or crypto). Wall Street insiders are already positioning themselves... and he insists you should, too, before it's too late.September 20 at 2:00 AM | Stansberry Research (Ad)Amesite stock doubles as NurseMagic™ drives 63% revenue growthSeptember 11, 2025 | msn.comAmesite Inc. Reports 63% Revenue Growth for NurseMagic™ Platform Following Enterprise Model LaunchSeptember 11, 2025 | quiverquant.comQAmesite Reports 63% Revenue Growth from NurseMagic™ Enterprise; Announces Launch of AI-Powered Government Form-Fill Automation to Reduce Reporting BurdenSeptember 11, 2025 | globenewswire.comSee More Amesite Headlines Get Earnings Announcements in your inboxWant to stay updated on the latest earnings announcements and upcoming reports for companies like Amesite? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Amesite and other key companies, straight to your email. Email Address About AmesiteAmesite (NASDAQ:AMST), Inc. (NASDAQ: AMST) is a software company specializing in AI-driven digital learning and training solutions. Its cloud-based platform enables organizations to create, manage and deliver customized online courses and professional development programs. Leveraging machine learning and natural language processing, the platform offers real-time analytics, adaptive content recommendations, multimedia assessments and community collaboration tools to support both synchronous and asynchronous learning. The company’s primary end markets include corporate enterprises, higher education institutions, government agencies and nonprofit organizations. Clients use Amesite’s platform to streamline employee onboarding, upskill workers in emerging technologies, deliver continuing education courses and facilitate compliance training. The platform integrates with leading learning management systems, video conferencing applications and collaboration suites to deliver a cohesive user experience across devices and operating environments. Founded and led by Dr. Fatih Karahan, who serves as Chief Executive Officer, Amesite is headquartered in Charlotte, North Carolina. The company completed its business combination and began trading on the Nasdaq in late 2021. Since its inception, Amesite has pursued partnerships with academic institutions and industry groups across North America to enhance its content library and expand its footprint in key sectors such as finance, healthcare and information technology.View Amesite ProfileRead more More Earnings Resources from MarketBeat Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Latest Articles Berkshire-Backed Lennar Slides After Weak Q3 EarningsWall Street Eyes +30% Upside in Synopsys After Huge Earnings FallRH Stock Slides After Mixed Earnings and Tariff ConcernsCelsius Stock Surges After Blowout Earnings and Pepsi DealWhy DocuSign Could Be a SaaS Value Play After Q2 EarningsWhy Broadcom's Q3 Earnings Were a Huge Win for AVGO BullsAffirm Crushes Earnings Expectations, Turns Bears into Believers Upcoming Earnings Micron Technology (9/23/2025)AutoZone (9/23/2025)Cintas (9/24/2025)Costco Wholesale (9/25/2025)Accenture (9/25/2025)NIKE (9/30/2025)PepsiCo (10/9/2025)BlackRock (10/10/2025)Fastenal (10/13/2025)Wells Fargo & Company (10/14/2025) Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
